Genovate Biotechnology Revenue

In the year 2025, Genovate Biotechnology had annual revenue of 492.41M TWD, down -3.61%. Genovate Biotechnology had revenue of 119.40M in the quarter ending December 31, 2025, with 1.00% growth.

Revenue

492.41M

Revenue Growth

-3.61%

P/S Ratio

6.45

Revenue / Employee

2.59M

Employees

190

Market Cap

3.17B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	492.41M	-18.45M	-3.61%
Dec 31, 2024	510.86M	-17.66M	-3.34%
Dec 31, 2023	528.51M	89.75M	20.46%
Dec 31, 2022	438.76M	4.51M	1.04%
Dec 31, 2021	434.25M	-38.47M	-8.14%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SYN-TECH Chem. & Pharm.	1.30B
Intech Biopharm	107.53M
Shine-On BioMedical	30.00M
BRIM Biotechnology	5.49M
HeXun Biosciences	293.23M
Apex Biotechnology	1.94B
Syngen Biotech	2.14B
BioGend Therapeutics	222.34M

Revenue Rankings